Rome, Italy – A renewed campaign, “Crohnostorie” (Crohn’s Stories), is underway in Italy, aiming to amplify the voices of individuals living with Crohn’s disease. The initiative seeks to foster a deeper understanding of the condition and improve the doctor-patient relationship. The campaign’s resurgence comes at a critical time, as patients continue to navigate the challenges of managing a chronic illness and advocating for their needs within the healthcare system. Crohn’s disease, a type of inflammatory bowel disease (IBD), affects the gastrointestinal tract, causing inflammation, pain, and a range of other symptoms that can significantly impact quality of life.
The importance of open communication between patients and their physicians is central to the “Crohnostorie” campaign. Effective dialogue can lead to more personalized treatment plans and improved patient outcomes. As of 2023, approximately 1.4 million Europeans were living with Crohn’s disease or ulcerative colitis, another form of IBD, according to the European Crohn’s and Colitis Organisation (ECCO). ECCO IBD Statistics The condition typically manifests between the ages of 15 and 35, although it can occur at any age. While there is no cure for Crohn’s disease, various treatments are available to manage symptoms and induce remission.
Understanding Crohn’s Disease: Symptoms, Causes, and Diagnosis
Crohn’s disease is characterized by chronic inflammation of the digestive tract, most commonly affecting the slight intestine and colon. Symptoms can vary widely in severity and may include abdominal pain, diarrhea, rectal bleeding, weight loss, fatigue, and fever. Some individuals may also experience extraintestinal manifestations, such as joint pain, skin rashes, and eye inflammation. The exact cause of Crohn’s disease remains unknown, but It’s believed to involve a combination of genetic predisposition, immune system dysfunction, and environmental factors. Mayo Clinic – Crohn’s Disease
Diagnosing Crohn’s disease can be challenging, as its symptoms can mimic those of other gastrointestinal disorders. Doctors typically employ a combination of diagnostic tests, including blood tests, stool tests, colonoscopy, endoscopy, and imaging studies such as CT scans and MRI. A colonoscopy, which involves inserting a flexible tube with a camera into the colon, allows doctors to visualize the intestinal lining and collect tissue samples for microscopic examination. Biopsies can help confirm the presence of inflammation and identify characteristic features of Crohn’s disease.
The Doctor-Patient Relationship: A Key Component of Care
Morena Caira, Head of Medical Affairs Immunology at AbbVie Italia, emphasized the crucial role of the doctor-patient relationship in managing Crohn’s disease. According to her LinkedIn profile, Dr. Caira received her medical degree from the Catholic University in Rome in 2003. Morena Caira – AbbVie | LinkedIn She has extensive experience in the field of immunology and has been involved in medical affairs for several years. Dr. Caira’s work at AbbVie focuses on improving the lives of patients with immune-mediated diseases, including Crohn’s disease.
“Effective communication is paramount,” Dr. Caira stated in discussions surrounding the campaign. “Patients need to sense comfortable discussing their symptoms, concerns, and treatment goals with their doctors. Conversely, physicians need to actively listen to their patients and provide clear, concise information about their condition and treatment options.” She highlighted the importance of shared decision-making, where patients and doctors collaborate to develop a treatment plan that aligns with the patient’s individual needs and preferences.
“Crohnostorie” Campaign: Giving Voice to Patients
The “Crohnostorie” campaign aims to create a platform for patients to share their experiences with Crohn’s disease, fostering a sense of community and reducing the stigma associated with the condition. Through personal stories, videos, and online forums, the campaign seeks to raise awareness about the challenges faced by individuals living with Crohn’s disease and advocate for improved access to care. The campaign also provides educational resources for patients, families, and healthcare professionals.
The initiative recognizes that living with Crohn’s disease extends beyond physical symptoms. Patients often grapple with emotional and psychological challenges, such as anxiety, depression, and social isolation. The “Crohnostorie” campaign aims to address these issues by providing support and resources for mental health and well-being. Connecting with others who understand the challenges of living with Crohn’s disease can be incredibly empowering and can help patients cope with the emotional toll of the condition.
Treatment Options for Crohn’s Disease
Treatment for Crohn’s disease typically involves a combination of medications, dietary modifications, and, in some cases, surgery. Medications commonly used to manage Crohn’s disease include anti-inflammatory drugs, immunosuppressants, and biologics. Anti-inflammatory drugs, such as corticosteroids and aminosalicylates, can help reduce inflammation in the digestive tract. Immunosuppressants work by suppressing the immune system, which can help control the inflammatory response. Biologics are a newer class of drugs that target specific proteins involved in the inflammatory process.
Dietary modifications can also play a role in managing Crohn’s disease symptoms. Some individuals locate that avoiding certain foods, such as dairy products, gluten, or spicy foods, can help reduce their symptoms. But, there is no one-size-fits-all diet for Crohn’s disease, and it is important to work with a registered dietitian to develop a personalized eating plan. Surgery may be necessary in some cases to remove damaged portions of the intestine or to treat complications such as strictures or fistulas.
The Role of Research and Innovation
Ongoing research is crucial for developing novel and more effective treatments for Crohn’s disease. Researchers are investigating the underlying causes of the condition, identifying new drug targets, and exploring innovative therapies such as stem cell transplantation and fecal microbiota transplantation. Dr. Caira, in addition to her role at AbbVie, has been involved as an Associate Editor for BMC Infectious Diseases Journal and Associate Faculty Member at Faculty of 1000 since 2012 and 2011, respectively, demonstrating a commitment to medical research. Morena Caira – The Org
Fecal microbiota transplantation (FMT) involves transferring fecal matter from a healthy donor into the recipient’s colon to restore a healthy balance of gut bacteria. This approach has shown promise in treating certain gastrointestinal disorders, including recurrent Clostridioides difficile infection, and is being investigated as a potential treatment for Crohn’s disease. Stem cell transplantation involves replacing damaged immune cells with healthy stem cells, which can help reset the immune system and reduce inflammation.
Looking Ahead: The Future of Crohn’s Disease Management
The future of Crohn’s disease management is likely to involve a more personalized approach, tailored to the individual patient’s genetic makeup, immune profile, and disease characteristics. Advances in genomics and proteomics are enabling researchers to identify biomarkers that can predict disease progression and response to treatment. This information can be used to develop targeted therapies that are more effective and have fewer side effects.
The “Crohnostorie” campaign represents a significant step towards empowering patients and improving the quality of care for individuals living with Crohn’s disease. By fostering open communication, raising awareness, and advocating for research and innovation, the campaign aims to create a brighter future for those affected by this chronic condition. The next phase of the campaign, scheduled for late 2026, will focus on expanding its reach to underserved communities and providing access to educational resources in multiple languages.
If you or someone you know is living with Crohn’s disease, please consider sharing your story and joining the “Crohnostorie” community. Your voice can make a difference. For more information about Crohn’s disease and available resources, please visit the Crohn’s & Colitis Foundation website: Crohn’s & Colitis Foundation. We encourage you to share this article and leave your thoughts in the comments below.
Worth a look